Peritumoral lymphatic microvessel density is related to poor prognosis in lung adenocarcinoma: A retrospective study of 65 cases

Zhang,Bi-Cheng; Guan,Sha; Zhang,Ya-Fei; Yao,Guo-Qing; Yang,Bo; Zhao,Yong; Rao,Zhi-Guo; Gao,Jian-Fei

doi:10.3892/etm.2012.470

Peritumoral lymphatic microvessel density is related to poor prognosis in lung adenocarcinoma: A retrospective study of 65 cases

Authors:
- Bi-Cheng Zhang
- Sha Guan
- Ya-Fei Zhang
- Guo-Qing Yao
- Bo Yang
- Yong Zhao
- Zhi-Guo Rao
- Jian-Fei Gao
View Affiliations

Affiliations: Department of Oncology, Wuhan General Hospital of Guangzhou Command, People's Liberation Army, Wuhan 430070, P.R. China
Published online on: February 3, 2012 https://doi.org/10.3892/etm.2012.470
Pages: 636-640

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Although recent investigations have identified that lymphangiogenesis is associated with regional lymph node metastasis and tumor prognosis in non-small cell lung cancer (NSCLC), peritumoral lymphatic microvessel density (LMVD) and its prognostic significance in lung adenocarcinoma remain unknown. In the present study, we assessed peritumoral LMVD in lung adenocarcinoma and investigated its correlation with patient prognosis. Using immunohistochemistry (SP method), the D2-40-positive peritumoral LMVD count in lung adenocarcinoma was found to be 11.56±10.73, which was higher than intratumoral LMVD (P<0.001), and was found to be associated with lymphatic metastasis (P=0.003) and pTNM staging (P=0.046). Furthermore, a significant difference in the patient overall survival time was demonstrated between tumors with a high peritumoral LMVD and those with a low peritumoral LMVD (P=0.005). Finally, using multivariate analysis, it was determined that peritumoral LMVD, lymphatic metastasis and pTNM staging were independent prognostic factors. In conclusion, the results suggest that D2-40-positive peritumoral LMVD may predict the prognosis of lung adenocarcinoma.

View Figures

View References

1.	Tiseo M, Bartolotti M, Gelsomino F and Ardizzoni A: First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype. Expert Rev Anticancer Ther. 9:425–435. 2009. View Article : Google Scholar : PubMed/NCBI
2.	Alitalo K, Tammela T and Petrova TV: Lymphangiogenesis in development and human disease. Nature. 438:946–953. 2005. View Article : Google Scholar : PubMed/NCBI
3.	Stacker SA, Farnsworth RH, Karnezis T, et al: Molecular pathways for lymphangiogenesis and their role in human disease. Novartis Found Symp. 281:38–43. 2007. View Article : Google Scholar : PubMed/NCBI
4.	Mandriota SJ, Jussila L, Jeltsch M, et al: Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 20:672–682. 2001. View Article : Google Scholar
5.	Stacker SA, Caesar C, Baldwin ME, et al: Vascular endothelial growth factor-D promotes the metastatic spread of cancer via the lymphatics. Nat Med. 7:186–191. 2001. View Article : Google Scholar : PubMed/NCBI
6.	Schoppmann SF, Birner P, Stöckl J, et al: Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol. 161:947–956. 2002. View Article : Google Scholar
7.	Schoppmann SF, Fenzl A, Nagy K, et al: VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery. 139:839–846. 2006. View Article : Google Scholar : PubMed/NCBI
8.	Zhang B, Wang J, Gao J, et al: Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma. J Cell Biochem. 107:134–143. 2009. View Article : Google Scholar : PubMed/NCBI
9.	Renyi-Vamos F, Tovari J, Fillinger J, et al: Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer. Clin Cancer Res. 11:7344–7353. 2005. View Article : Google Scholar : PubMed/NCBI
10.	Takanami I: Lymphatic microvessel density using D2-40 is associated with nodal metastasis in non-small cell lung cancer. Oncol Rep. 15:437–442. 2006.PubMed/NCBI
11.	Kadota K, Huang CL, Liu D, et al: The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients. Eur J Cancer. 44:105710–105767. 2008. View Article : Google Scholar : PubMed/NCBI
12.	Iwakiri S, Nagai S, Katakura H, et al: D2-40-positive lymphatic vessel density is a poor prognostic factor in squamous cell carcinoma of the lung. Ann Surg Oncol. 16:1678–1685. 2009. View Article : Google Scholar : PubMed/NCBI
13.	Faoro L, Hutto JY, Salgia R, et al: Lymphatic vessel density is not associated with lymph node metastasis in non-small cell lung carcinoma. Arch Pathol Lab Med. 132:1882–1888. 2008.PubMed/NCBI
14.	Travis WD, Brambilla E, Noguchi M, et al: International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of lung adenocarcinoma. J Thorac Oncol. 6:244–285. 2011. View Article : Google Scholar
15.	Kahn HJ and Marks A: A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest. 82:1255–1257. 2002. View Article : Google Scholar : PubMed/NCBI
16.	Kato S, Shimoda H, Ji RC and Miura M: Lymphangiogenesis and expression of specific molecules as lymphatic endothelial cell markers. Anat Sci Int. 81:71–83. 2006. View Article : Google Scholar : PubMed/NCBI
17.	Braun M, Wardelmann E, Debald M, et al: Detection of lymphovascular invasion in vulvar cancer by D2-40 (podoplanin) as a predictor for inguinal lymph node metastases. Onkologie. 32:732–738. 2009. View Article : Google Scholar : PubMed/NCBI
18.	Kitano H, Kageyama S, Hewitt SM, et al: Podoplanin expression in cancerous stroma induces lymphangiogenesis and predicts lymphatic spread and patient survival. Arch Pathol Lab Med. 134:1520–1527. 2010.PubMed/NCBI
19.	Min KH, Park SJ, Lee KS, et al: Clinical usefulness of D2-40 in non-small cell lung cancer. Lung. 189:57–63. 2011. View Article : Google Scholar : PubMed/NCBI
20.	Raica M, Cimpean AM, Ceausu R and Ribatti D: Lymphatic microvessel density, VEGF-C, and VEGFR-3 expression in different molecular types of breast cancer. Anticancer Res. 31:1757–1764. 2011.PubMed/NCBI
21.	Kim HS, Sung W, Lee S, Chang SG and Park YK: Lymphatic vessel densities of lymph node-negative prostate adenocarcinoma in Korea. Pathol Res Pract. 205:249–254. 2009. View Article : Google Scholar : PubMed/NCBI
22.	Saad RS, Kordunsky L, Liu YL, Denning KL, Kandil HA and Silverman JF: Lymphatic microvessel density as prognostic marker in colorectal cancer. Mod Pathol. 19:1317–1323. 2006. View Article : Google Scholar : PubMed/NCBI
23.	Valencak J, Heere-Ress E, Kopp T, Schoppmann SF, Kittler H and Pehamberger H: Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma. Eur J Cancer. 40:358–364. 2004. View Article : Google Scholar
24.	Ali MA: Lymphatic microvessel density and the expression of lymphangiogenic factors in oral squamous cell carcinoma. Med Princ Pract. 17:486–492. 2008. View Article : Google Scholar : PubMed/NCBI
25.	Dadras SS, Paul T, Bertoncini J, et al: Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol. 162:1951–1960. 2003. View Article : Google Scholar : PubMed/NCBI
26.	Maula SM, Luukkaa M, Grénman R, Jackson D, Jalkanen S and Ristamäki R: Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res. 63:1920–1926. 2003.
27.	Horiguchi A, Ito K, Sumitomo M, Kimura F, Asano T and Hayakawa M: Intratumoral lymphatics and lymphatic invasion are associated with tumor aggressiveness and poor prognosis in renal cell carcinoma. Urology. 71:928–932. 2008. View Article : Google Scholar : PubMed/NCBI
28.	Padera TP, Stoll BR, Tooredman JB, Capen D, Di Tomaso E and Jain RK: Pathology: cancer cells compress intratumour vessels. Nature. 427:6952004. View Article : Google Scholar : PubMed/NCBI
29.	Padera TP, Kadambi A, Di Tomaso E, et al: Lymphatic metastasis in the absence of functional intratumor lymphatics. Science. 296:1883–1886. 2002. View Article : Google Scholar : PubMed/NCBI
30.	Ji RC: Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: new insights into intratumoral and peritumoral lymphatics. Cancer Metastasis Rev. 25:677–694. 2006.PubMed/NCBI
31.	Wang XL, Fang JP, Tang RY and Chen XM: Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases. BMC Cancer. 10:2992010. View Article : Google Scholar
32.	Gao Y, Liu Z, Gao F and Meng XY: High density of peritumoral lymphatic vessels is a potential prognostic marker of endometrial carcinoma: a clinical immunohistochemical method study. BMC Cancer. 10:1312010. View Article : Google Scholar
33.	Adachi Y, Nakamura H, Kitamura Y, et al: Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases. Pathol Int. 57:171–177. 2007. View Article : Google Scholar